[1]
“Immune-Directed Therapy for Type 1 Diabetes at the Clinical Level: The Immune Tolerance Network (ITN) Experience”, Rev Diabet Stud, vol. 9, no. 4, Aug. 2023, Accessed: Sep. 21, 2025. [Online]. Available: https://www.diabeticstudies.org/index.php/RDS/article/view/185